019170 — SHINPOONG PHARMACEUTICAL CO Share Price
0.000.00%
Last trade - 00:00- KR₩375bn
- KR₩376bn
- KR₩221bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.5 | ||
| Price to Tang. Book | 1.53 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.73 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -7.68% | ||
| Return on Equity | -5.65% | ||
| Operating Margin | -9.25% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 197,750.77 | 189,237.23 | 209,287.63 | 200,228.58 | 221,094.07 | n/a | n/a | 3.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +0.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Shin Pooong Pharm., Co. Ltd is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. The Company's product portfolio consists of antibiotics, cardiovascular drugs, anti-cancer drugs, psychoneurotic drugs, antirheumatic drugs, antidiabetics, antifungal agents, antihistamines, antiviral agents, benign prostatic hyperplasia (BPH) drugs and trichogens. The Company also provides active pharmaceutical ingredients (APIs) synthesized by the Company, including non-steroidal anti-inflammatory drugs (NSAIDs), cardiovascular drugs, anti-ulcer drugs, respiratory drugs, antispasmodics drugs and others. The Company distributes its products within domestic market and to overseas markets.
Directors
- Je Man Yoo CEO (64)
- Chun Sik Noh MDR (68)
- Cheong Joo MEO (47)
- Jin Gyu Park OTH (55)
- Hyeok Rae Kim OTH (51)
- Chung Hwan Park OTH (63)
- Jae Hong Park OTH (59)
- Ju Yeong Sung OTH (55)
- Su Deok Yoon OTH (83)
- Hyeon Je Cho NID (49)
- Seung Cheol Han NID (57)
- Jin Yeong Jung NID (61)
- Chan Ho Lee NID (48)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 23rd, 1986
- Public Since
- January 20th, 1990
- No. of Shareholders
- 146,231
- No. of Employees
- 840
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KSE
- Shares in Issue
- 49,271,029
- Address
- 7, Wonsi-ro, Danwon-gu, ANSAN, 15610
- Web
- https://shinpoong.co.kr/
- Phone
- +82 314916191
- Auditors
- Samil Accounting Corp.
Upcoming Events for 019170
Q2 2025 Shinpoong Pharmaceutical Co Ltd Earnings Release
Similar to 019170
Aprogen Biologics
Korea Exchange - KSE
Boryung
Korea Exchange - KSE
Bukwang Pharm Co
Korea Exchange - KSE
Chong Kun Dang Pharmaceutical
Korea Exchange - KSE
CKD Bio
Korea Exchange - KSE
FAQ
What is the SHINPOONG PHARMACEUTICAL CO share price?
As of Today at 23:12 UTC, shares in SHINPOONG PHARMACEUTICAL CO are trading at KR₩7,770. This share price information is delayed by 15 minutes.
How has the SHINPOONG PHARMACEUTICAL CO share price performed this year?
Shares in SHINPOONG PHARMACEUTICAL CO last closed at KR₩7,770 and the price had moved by -41.62% over the past 365 days. In terms of relative price strength the SHINPOONG PHARMACEUTICAL CO share price has underperformed the FTSE Developed Asia Pacific Index by -40.95% over the past year.
What are the analyst and broker recommendations for SHINPOONG PHARMACEUTICAL CO?
There is no consensus recommendation for this security.
Find out moreWhat is the SHINPOONG PHARMACEUTICAL CO dividend yield?
SHINPOONG PHARMACEUTICAL CO does not currently pay a dividend.
Does SHINPOONG PHARMACEUTICAL CO pay a dividend?
SHINPOONG PHARMACEUTICAL CO does not currently pay a dividend.
When does SHINPOONG PHARMACEUTICAL CO next pay dividends?
SHINPOONG PHARMACEUTICAL CO does not currently pay a dividend.
How do I buy SHINPOONG PHARMACEUTICAL CO shares?
To buy shares in SHINPOONG PHARMACEUTICAL CO you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of SHINPOONG PHARMACEUTICAL CO?
As of the previous close price of KR₩7,770, shares in SHINPOONG PHARMACEUTICAL CO had a market capitalisation of KR₩375bn.
Where are SHINPOONG PHARMACEUTICAL CO shares listed?
Here are the trading details for SHINPOONG PHARMACEUTICAL CO:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 019170
What kind of share is SHINPOONG PHARMACEUTICAL CO?
Based on an overall assessment of its quality, value and momentum SHINPOONG PHARMACEUTICAL CO is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a SHINPOONG PHARMACEUTICAL CO share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the SHINPOONG PHARMACEUTICAL CO share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SHINPOONG PHARMACEUTICAL CO. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -28.07%.
As of the last closing price of KR₩7,770, shares in SHINPOONG PHARMACEUTICAL CO were trading -28.87% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the SHINPOONG PHARMACEUTICAL CO PE Ratio?
The SHINPOONG PHARMACEUTICAL CO PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩7,770.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of SHINPOONG PHARMACEUTICAL CO?
SHINPOONG PHARMACEUTICAL CO's management team is headed by:
- Je Man Yoo - CEO
- Chun Sik Noh - MDR
- Cheong Joo - MEO
- Jin Gyu Park - OTH
- Hyeok Rae Kim - OTH
- Chung Hwan Park - OTH
- Jae Hong Park - OTH
- Ju Yeong Sung - OTH
- Su Deok Yoon - OTH
- Hyeon Je Cho - NID
- Seung Cheol Han - NID
- Jin Yeong Jung - NID
- Chan Ho Lee - NID